+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Japan - Healthcare, Regulatory and Reimbursement Landscape

  • PDF Icon

    Report

  • 167 Pages
  • April 2021
  • Region: Japan
  • GlobalData
  • ID: 5317507
Description Jump to:
Japan - Healthcare, Regulatory and Reimbursement Landscape

Summary

The industry analysis specialist, has released its latest report, "Japan - Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.

The Japanese pharmaceutical market is the third largest in the world in terms of value. Japan’s pharmaceutical market, based on production value, increased from ¥6,894B in 2013 to ¥9,281B in 2020 at a Compound Annual Growth Rate (CAGR) of 4.34%. In terms of US Dollars, the market increased from $70.64B in 2013 to $86.96B in 2020 at a CAGR of 3.01%. It is forecast to reach about $100.88B in 2025. The increasing elderly population, chronic and lifestyle diseases, incentives for innovation, and short regulatory approval timelines are the main factors driving the growth of the Japanese pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Japan, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, Takeda, and Astellas Pharma
  • Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Siemens Healthineers, DePuy Synthes, Olympus, and Terumo
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Japanese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Japan’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Japan’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about the Japanese Healthcare Market
2.3 Key Highlights: Healthcare Startups in Japan
2.4 Key Events: Japanese Healthcare Timeline, 2014-2020
2.5 Key Events: Japanese Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Japan, 2020
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Japan
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Japan
3.7 COVID-19 Epidemiology, Japan
3.8 COVID-19 Impact and Developments in the Healthcare Market, Japan
3.9 COVID-19 Clinical Trials Landscape, Japan
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Japan, 2020-2021
6.2 Deal Analysis: Medical Device Market, Japan, 2020-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Japan
7.2 HealthTech Deals Landscape, Japan
7.3 Key HealthTech Deals, Japan
7.4 Adoption of Technology in Healthcare, Japan
7.5 Key Development Technologies, Japan
7.6 Regulatory Scenario Covering Use of Technology in Healthcare, Japan
7.7 HealthTech Landscape: Benefits and Risks, Japan
8. Market Access
8.1 Overview of Healthcare System, Japan
8.2 Reimbursement Process, Japan
8.3 Overview of Insurance Providers, Japan
8.4 Healthcare Spending and Prescription Drug Price Trend, Japan
8.5 Pricing Policies, Japan
8.6 Regulatory Landscape, Japan
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, Japan
8.6.3 Marketing Authorization for Medical Devices, Japan
8.6.4 Marketing Authorization for Regenerative Medical Products, Japan
8.6.5 Intellectual Property Rights, Patent, Japan
8.6.6 Intellectual Property Rights, Trademark, Japan
8.6.7 Clinical Trial Regulation Process, Japan
8.6.8 Pharmaceutical Clinical Trials Landscape, Japan
8.6.9 Medical Devices Clinical Trials Landscape, Japan
8.6.10 Market Authorization for Pharmaceutical Manufacturing, Japan
8.6.11 Market Authorization for Medical Devices Manufacturing, Japan
8.6.10 Pharmaceutical Export and Import, Japan
8.6.13 Pharmaceutical Advertisement Regulations, Japan
8.6.14 Pharmacy Regulations, Japan
8.6.15 Labeling and Packaging Regulations, Japan
9. Country Healthcare Landscape
9.1 Japanese Healthcare Policy Highlights
9.2 Healthcare Facilities, Japan
9.3 Healthcare Parameters, Japan
9.4 Life Expectancy and Immunization Rate, Japan
9.5 Environmental Health, Japan
9.6 Healthcare Personnel, Japan
9.7 Disease Burden, Japan
9.8 Healthcare Expenditure, Japan
10 Trade Associations, Japan
11 Trade Fairs, Japan
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer
List of Tables
  • Table 1: Biopharmaceuticals Composition Ratio (%), Japan, 2019
  • Table 2: Approved Biosimilars, Japan, 2017-2021
  • Table 3: Major Therapeutic Areas by Production Value ($B), Japan, 2019
  • Table 4: COVID-19 Indicators (Number of Cases), Global and Japan, 2020-2021
  • Table 5: COVID-19-Related Travel Restrictions, Japan, 2020-2021
  • Table 6: COVID-19 Vaccines Development Landscape, Japan, 2020-2021
  • Table 7: Approved Medical Products for COVID-19, Japan, 2020-2021
  • Table 8: Approved Medical Devices for COVID-19, Japan, 2020-2021
  • Table 9: COVID-19 IVD Products (April ‘20- April ‘21), Japan, 2020-2021
  • Table 10: Medical Device Market, Japan, Major Segments ($B), 2020
  • Table 11: General Surgery Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
  • Table 12: Orthopedic Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
  • Table 13: Cardiovascular Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
  • Table 14: Wound Care Management Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
  • Table 15: Nephrology and Urology Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
  • Table 16: Medical Device Reimbursement Assessment Categories, Japan, 2018
  • Table 17: Public Insurance Schemes, Japan, 2019
  • Table 18: Types of Premiums, Japan, 2020
  • Table 19: Classification and Regulation Regarding Medical Devices, Japan, 2021
  • Table 20: Classification of Regenerative Medical Products, Japan, 2021
  • Table 21: Patent Fees, Japan, 2021
  • Table 22: Trademark Fees, Japan, 2021
  • Table 23: Headings and their Sequence in Package Inserts, Japan, 2021

List of Figures
  • Figure 1: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
  • Figure 2: Medical Device Market, Japan, Revenue ($B), 2015-2020
  • Figure 3: Healthcare Startups in Japan, 2021
  • Figure 4: Number of Deals (2019-2020)
  • Figure 5: 2019-2020 Deal Overview by Region
  • Figure 6: Country Profile, Japan, 2020
  • Figure 7: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
  • Figure 8: Pharmaceutical Market, Japan, Revenue Forecast ($B and ¥B), 2021-2025
  • Figure 9: AMED Projects, Japan, 2019
  • Figure 10: Pharmaceutical Exports ($B), Japan, 2013-2020
  • Figure 11: Top Export Partners, Japan, 2020
  • Figure 12: Pharmaceutical Imports ($B), Japan, 2013-2020
  • Figure 13: Top Import Partners, Japan, 2020
  • Figure 14: Pharmaceutical Supply Channel, Japan, 2021
  • Figure 15: Generic Drugs Penetration Rate, Japan, 2005-2018
  • Figure 16: Pharmaceutical, Biotechnology, and Healthcare Clusters, Japan, 2021
  • Figure 17: OTC Medicines Market, Revenue ($B), Japan, 2013-2020
  • Figure 18: OTC Medicines Market, Major Distribution Channels ($B), Japan, 2020
  • Figure 19: OTC Medicines Market, Major Categories ($B), Japan, 2020
  • Figure 20: Major Therapeutic Areas by Production Value, Japan, 2019
  • Figure 21: COVID-19 Cases, Japan, 2020-2021
  • Figure 22: COVID-19 Deaths, Japan, 2020-2021
  • Figure 23: COVID-19 Fiscal Stimulus Timeline, Japan, 2020-2021
  • Figure 24: COVID-19 Vaccination Progress, Japan, 2021
  • Figure 25: COVID-19 Clinical Trials Count by Phase, Japan, 2020-2021
  • Figure 26: COVID-19 Clinical Trials Count by Trial Status, Japan, 2020-2021
  • Figure 27: Top Five COVID-19 Clinical Trials Sponsors by Trial Count, Japan, 2020-2021
  • Figure 28: Medical Devices Market, Japan, Revenue ($B), 2015-2020
  • Figure 29: Medical Devices Market, Japan, Revenue Forecast ($B), 2021-2025
  • Figure 30: AMED Projects for Medical Device, Japan, 2020
  • Figure 31: Medical Device Market, Japan, Major Segments (%), 2020
  • Figure 32: General Surgery Market, Japan, Revenue ($B), 2017-2025
  • Figure 33: General Surgery Market, Japan, Market Share of Major Players (%), 2019
  • Figure 34: Orthopedic Devices Market, Japan, Revenue ($B), 2017-2025
  • Figure 35: Orthopedic Devices Market, Japan, Market Share of Major Players (%), 2019
  • Figure 36: Cardiovascular Devices Market, Japan, Revenue ($B), 2017-2025
  • Figure 37: Cardiovascular Devices Market, Japan, Market Share of Major Players (%), 2019
  • Figure 38: Wound Care Management Market, Japan, Revenue ($B), 2017-2025
  • Figure 39: Wound Care Management Market, Japan, Market Share of Major Players (%), 2019
  • Figure 40: Nephrology and Urology Devices Market, Japan, Revenue ($B), 2017-2025
  • Figure 41: Nephrology and Urology Devices Market, Japan, Market Share of Major Players (%), 2019
  • Figure 42: Diagnostics Market, Japan, Revenue ($B), 2015-2020
  • Figure 43: Diagnostics Market, Japan, Revenue Forecast ($B), 2021-2025
  • Figure 44: Medical Devices Market, Revenue ($B) of Major Companies, Japan, 2019
  • Figure 45: Deal Value and Deal Count, Pharmaceutical Market, Japan, 2020-2021
  • Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Japan, 2020-2021
  • Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Japan, 2020-2021
  • Figure 48: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Japan, 2020-2021
  • Figure 49: Top Five Therapy Areas by Deal Count, Pharmaceutical Market, Japan, 2020-2021
  • Figure 50: M&A Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
  • Figure 51: VC Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
  • Figure 52: Medical Devices Market Deals by Deal Value ($M), Japan, 2020-2021
  • Figure 53: Medical Devices Market Deals by Deal Count, Japan, 2020-2021
  • Figure 54: Medical Devices Market Deals Share by Deal Value, Japan, 2020-2021
  • Figure 55: Medical Devices Market Deals Share by Deal Count, Japan, 2020-2021

Related Topics

Related Reports

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Medical Devices Reimbursement Market Size, Share & Trends Analysis Report By Payer (Public, Private), By Healthcare Setting (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 275 Pages
  • Global
From
Global Revenue Cycle Management Market Report and Forecast 2023-2031 - Product Image

Global Revenue Cycle Management Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029 - Product Image

Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029

  • Drug Pipelines
  • 139 Pages
  • Global
From
Global Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) - Forecast to 2028 - Product Image

Global Revenue Cycle Management Market by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) - Forecast to 2028

  • Report
  • 320 Pages
  • Global
From
Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 - Product Image

Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

  • Drug Pipelines
  • 151 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.